Naturally Acquired and Conjugate Vaccine-Induced Antibody to Haemophilus influenzae Type b (Hib) Polysaccharide in Malian Children: Serological Assessment of the Hib Immunization Program in Mali
Authors:
- Julia HutterJHJulia Hutter
- Marcela F. PasettiMPMarcela F. Pasetti
- Doh SanogoDSDoh Sanogo
- Milagritos D. TapiaMTMilagritos D. Tapia
- Samba O. SowSSSamba O. Sow
- Myron M. LevineMLMyron M. Levine
- 1 June 2012
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 86 (6) , 1026-1031
Abstract
Haemophilus influenzae type b (Hib) conjugate vaccine for infants (6, 10, and 14 weeks of age) was introduced into the Malian Expanded Program on Immunization in July 2005, to diminish invasive Hib disease in young children. Antibodies to Hib capsular polysaccharide (PRP) were measured in infants and toddlers from an area already served by the Hib immunization program (Bamako) and in unimmunized children of the same age in a district (Kangaba) where Hib immunization had not yet begun. Among vaccinated Bamako children 6–23 months of age, 77–93% exhibited PRP titers ≥ 1.0 μg/mL, indicating long-term protection, versus only 10–23% of Kangaba children of that age. High PRP antibody titers in immunized children persisted through 2 years of age. Moreover, ∼50% of Bamako children exhibited anti-PRP titers ≥ 5.0 μg/mL; a level that impedes Hib upper respiratory carriage, and may thereby diminish the Hib transmission to the unimmunized susceptible population (i.e., providing indirect protection).Keywords
This publication has 56 references indexed in Scilit:
- A comparative study to evaluate the safety and immunogenicity of two lots of Haemophilus influenzae type-B conjugate vaccine manufactured at different scalesVaccine, 2011
- Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate VaccineThe Pediatric Infectious Disease Journal, 2011
- Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trialBMC Infectious Diseases, 2010
- Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmesClinical Microbiology and Infection, 2010
- The Elimination of Haemophilus influenzae type b Meningitis Following Conjugate Vaccine Introduction in SenegalThe Pediatric Infectious Disease Journal, 2010
- Anti-Polyribosylribitol Phosphate Antibody Concentrations and Avidities in Children since the Start ofHaemophilus influenzaeType b Immunization of Infants in the United KingdomClinical and Vaccine Immunology, 2009
- Immunogenicity of a Fourth Dose of Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Antibody Persistence in Young Children from the United Kingdom Who Were Primed with Acellular or Whole-Cell Pertussis Component-Containing Hib Combinations in InfancyClinical and Vaccine Immunology, 2007
- Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early lifeArchives of Disease in Childhood - Fetal and Neonatal Edition, 2004
- Global reduction of Hib disease: what are the next steps? Proceedings of the meetingThe Journal of Pediatrics, 2003
- Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infantsThe Journal of Pediatrics, 1992